Use of maintenance rituximab (R) in the United States following R-based induction for follicular lymphoma (FL). 18F-fluorodeoxglucose (FDG) positron emission tomography (PET) versus FLIPI as a ...

Therapeutic outcome in prognostic subgroups of de-novo acute myeloid leukemia (AML) and the role of the age factor. A study in 1834 patients of 16 to 84 years No significant financial relationships to ...

Please provide your email address to receive an email when new articles are posted on . Lymphopenia at diagnosis or during follow-up can predict OS among patients with multiple myeloma. Researchers ...

Measuring the lymphocytes - white blood cells that fight infection - in a patient's blood can be used to predict outcomes in non-Hodgkin lymphoma patients who receive CAR T-cell therapy, according to ...

In the general population, it is unknown whether stress-related perinatal factors influence lymphocyte subset counts in neonates. The aim of this study was to assess the associations of perinatal ...

Lymphocytes are types of white blood cells important for fighting off infection and destroying cancer cells inside your body. There are three types of lymphocytes: Do you know the best thing about ...

(A) Principal component analysis (PCA) of lymphocyte subsets and factors such as age in Control, LC, and LC-PTB groups, and the joint analysis of LC & LC-PTB. PC1 and PC2 represent the first and ...

Neutrophil-to-lymphocyte ratio (NLR) is a significant prognostic indicator in myeloproliferative neoplasms, correlating with mortality and thrombotic risk. In polycythemia vera, an NLR of at least 5 ...

Credit: X4 Pharmaceuticals. The approval was based on data from the randomized, double-blind, placebo-controlled phase 3 4WHILM trial. Findings showed mavorixafor was associated with statistically ...